| NVP-BGT226 |
|
| (CAS 1245537-68-1) |
 |
| Description： |
NVP-BGT226(BGT 226) is a novel class I PI3K/mTOR inhibitor for PI3Kα/β/γ with IC50 of 4 nM/63 nM/38 nM.
NVP-BGT226 has entered phase I/II clinical trials for the treatment of advanced solid tumors (including breast cancer).
|
| Product No. |
KT00167 |
| Product Name |
NVP-BGT226 |
| Synonyms |
BGT226 |
| Formal Name |
|
| CAS Number |
1245537-68-1 |
| Molecular Formula |
C28H25F3N6O2.C4H4O4 |
| Formula Weight |
650.6 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
A66
AS-252424
AS-605240
AZD 6482
BAY 80-6946
BEZ235
BYL-719
CAL-101
CAL-130
CUDC-907
|
|
